HHS Plans ADR Overhaul For Drug Discount Rows
The U.S. Department of Health and Human Services is floating a proposal to streamline its in-house process to resolve claims between health care providers and drugmakers under a multibillion-dollar drug discount...To view the full article, register now.
Already a subscriber? Click here to view full article